In 2012, the Kidney Disease Improving Global Outcomes (KDIGO) guideline recommended the measurement of cystatin C in adults with eGFRcr between 45–60 mL/min/1.73 m2, particularly in cases where other indicators of kidney damage are absent to validate the diagnosis of CKD [19]. This evidence concerns the gene CST3 and kidney disorder.